Adar1 Capital Management, LLC Taysha Gene Therapies, Inc. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 177,707 shares of TSHA stock, worth $286,108. This represents 0.06% of its overall portfolio holdings.
Number of Shares
177,707
Previous 251,400
29.31%
Holding current value
$286,108
Previous $505 Million
39.16%
% of portfolio
0.06%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding TSHA
# of Institutions
130Shares Held
151MCall Options Held
48KPut Options Held
7.8K-
Avoro Capital Advisors LLC New York, NY20MShares$32.2 Million0.5% of portfolio
-
Morgan Stanley New York, NY17.6MShares$28.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$18.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$17.5 Million0.3% of portfolio
-
Octagon Capital Advisors LP New York, NY10.5MShares$16.8 Million4.03% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $77.9M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...